UK markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
34.83-0.30 (-0.85%)
At close: 04:00PM EST
34.90 +0.07 (+0.22%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 63.50B
Enterprise value 81.49B
Trailing P/E 12.07
Forward P/E 9.62
PEG ratio (5-yr expected) 1.31
Price/sales (ttm)1.50
Price/book (mrq)3.41
Enterprise value/revenue 2.19
Enterprise value/EBITDA 8.20

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-22.58%
S&P500 52-week change 3-7.75%
52-week high 346.97
52-week low 328.47
50-day moving average 335.18
200-day moving average 337.09

Share statistics

Avg vol (3-month) 35.18M
Avg vol (10-day) 34.67M
Shares outstanding 52.05B
Implied shares outstanding 6N/A
Float 81.95B
% held by insiders 10.03%
% held by institutions 114.08%
Shares short (12 Jan 2023) 47.5M
Short ratio (12 Jan 2023) 41.94
Short % of float (12 Jan 2023) 4N/A
Short % of shares outstanding (12 Jan 2023) 40.37%
Shares short (prior month 14 Dec 2022) 410.92M

Dividends & splits

Forward annual dividend rate 41.9
Forward annual dividend yield 45.34%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 45.32
Payout ratio 469.00%
Dividend date 311 Jan 2023
Ex-dividend date 416 Nov 2022
Last split factor 21226:1000
Last split date 321 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 51.00%
Operating margin (ttm)21.94%

Management effectiveness

Return on assets (ttm)5.78%
Return on equity (ttm)31.31%

Income statement

Revenue (ttm)29.32B
Revenue per share (ttm)14.56
Quarterly revenue growth (yoy)-22.60%
Gross profit (ttm)19.77B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)2.69
Quarterly earnings growth (yoy)99.60%

Balance sheet

Total cash (mrq)7.88B
Total cash per share (mrq)3.91
Total debt (mrq)20.99B
Total debt/equity (mrq)207.87
Current ratio (mrq)0.91
Book value per share (mrq)5.26

Cash flow statement

Operating cash flow (ttm)7.4B
Levered free cash flow (ttm)3.31B